Role of 18F-FDG PET/CT in Gastric Cancer
About the study
The objective of the study is to assess the value of PET/CT in diagnosis, staging, response evaluation, and relapse monitoring of gastric cancer.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- patients diagnosed as GC on surgically resected specimens;
- Patients with gastric and extragastric metastasis.
- patients with gastric cancer either operated or not.
EXCLUSION CRITERIA
Exclusion Criteria:
- Patients with second malignancy.
- Patient without proven pathology of cancer stomach.
- Severely ill patient (patient with disturbed conscious level, or couldn't lay supine during the imaging).
- uncontrolled diabetic patient with blood glucose level more than 200mgdl.
- pregnant women
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study Details
Contition
Gastric Cancer
Age
18 - 70
Participants Needed
50
Est. Completion Date
Jan 31, 2024
Treatment Type
OBSERVATIONAL
Sponsor
Sohag University
ClinicalTrials.gov NCT Identifier
NCT05687552
Study Number
Gastric Cancer
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?